Progesterone
Names | |
---|---|
IUPAC name | |
Systematic IUPAC name
(1S,3aS,3bS,9aR,9bS,11aS)-1-Acetyl-9a,11a-dimethyl-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one | |
Other names
P4;[1] Pregnenedione
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard
|
100.000.318 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C21H30O2 | |
Molar mass | 314.469 g/mol |
Melting point | 126 |
log P | 4.04[4] |
Pharmacology | |
G03DA04 (WHO) | |
subcutaneous injection, subcutaneous implant
| |
Pharmacokinetics: | |
OMP: <10%[5][6] | |
• | |
) | |
OMP: 16–18 hours[5][6][11] IM: 22–26 hours[6][12] SC: 13–18 hours[12] | |
Renal
| |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Progesterone (P4) is an
In addition to its role as a natural hormone, progesterone is also used as a medication, such as in combination with
Biological activity
Progesterone is the most important progestogen in the body. As a potent
Progesterone, through its
Progesterone and some of its metabolites, such as
Progesterone modulates the activity of
Biological function
Hormonal interactions
Progesterone has a number of physiological effects that are amplified in the presence of
Elevated levels of progesterone potently reduce the sodium-retaining activity of aldosterone, resulting in natriuresis and a reduction in extracellular fluid volume. Progesterone withdrawal, on the other hand, is associated with a temporary increase in sodium retention (reduced natriuresis, with an increase in extracellular fluid volume) due to the compensatory increase in aldosterone production, which combats the blockade of the mineralocorticoid receptor by the previously elevated level of progesterone.[43]
Early sexual differentiation
Progesterone plays a role in early human sexual differentiation.
During early fetal development, the undifferentiated gonads can develop into either testes or ovaries. The presence of the
Reproductive system
Progesterone has key effects via non-genomic signalling on human sperm as they migrate through the female tract before
Progesterone is sometimes called the "hormone of pregnancy",[54] and it has many roles relating to the development of the fetus:
- Progesterone converts the anovulatory dysfunctional uterine bleeding.
- During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy.[56]
- Progesterone decreases contractility of the uterine preterm labor.[56] Studies have shown that in women who are pregnant with a single fetus, asymptomatic in the prenatal stage, and at a high risk of giving pre-term birth spontaneously, vaginal progesterone medication has been found to be effective in preventing spontaneous pre-term birth. Women who are at a high risk of giving pre-term birth spontaneously are those who have a short cervix of less than 25 mm or have previously given pre-term birth spontaneously. Although pre-term births are generally considered to be less than 37 weeks, these studies found that vaginal progesterone is associated with fewer pre-term births of less than 34 weeks.[57]
- A drop in progesterone levels is possibly one step that facilitates the onset of labor.
- In addition, progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production.
The
Breasts
Lobuloalveolar development
Progesterone plays an important role in
Ductal development
Though to a far lesser extent than estrogen, which is the major mediator of mammary ductal development (via the
Breast cancer risk
Progesterone also appears to be involved in the
Skin health
The
Hormone replacement therapy, consisting of systemic treatment with estrogen alone or in combination with a progestogen, has well-documented and considerable beneficial effects on the skin of postmenopausal women.[70][71] These benefits include increased skin collagen content, skin thickness and elasticity, and skin hydration and surface lipids.[70][71] Topical estrogen has been found to have similar beneficial effects on the skin.[70] In addition, a study has found that topical 2% progesterone cream significantly increases skin elasticity and firmness and observably decreases wrinkles in peri- and postmenopausal women.[71] Skin hydration and surface lipids, on the other hand, did not significantly change with topical progesterone.[71]
These findings suggest that progesterone, like estrogen, also has beneficial effects on the skin, and may be independently protective against skin aging.[71]
Sexuality
Libido
Progesterone and its neurosteroid active metabolite allopregnanolone appear to be importantly involved in libido in females.[72]
Homosexuality
Dr. Diana Fleischman, of the University of Portsmouth, and colleagues looked for a relationship between progesterone and sexual attitudes in 92 women. Their research, published in the Archives of Sexual Behavior found that women who had higher levels of progesterone scored higher on a questionnaire measuring homoerotic motivation. They also found that men who had high levels of progesterone were more likely to have higher homoerotic motivation scores after affiliative priming compared to men with low levels of progesterone.[73][74][75][76]
Nervous system
Progesterone, like pregnenolone and dehydroepiandrosterone (DHEA), belongs to an important group of endogenous steroids called neurosteroids. It can be metabolized within all parts of the central nervous system.[77]
Neurosteroids are
Brain damage
Previous studies have shown that progesterone supports the normal development of neurons in the brain, and that the hormone has a protective effect on damaged brain tissue. It has been observed in animal models that females have reduced susceptibility to traumatic brain injury and this protective effect has been hypothesized to be caused by increased circulating levels of estrogen and progesterone in females.[80]
Proposed mechanism
The mechanism of progesterone protective effects may be the reduction of inflammation that follows brain trauma and hemorrhage.[81][82]
Damage incurred by traumatic brain injury is believed to be caused in part by mass
Progesterone has also been shown to prevent apoptosis in neurons, a common consequence of brain injury.[85] It does so by inhibiting enzymes involved in the apoptosis pathway specifically concerning the mitochondria, such as activated caspase 3 and cytochrome c.
Not only does progesterone help prevent further damage, it has also been shown to aid in
Addiction
Progesterone enhances the function of
- Sex differences in hormone levels may induce women to respond differently than men to nicotine. When women undergo cyclic changes or different hormonal transition phases (menopause, pregnancy, adolescence), there are changes in their progesterone levels.[90] Therefore, females have an increased biological vulnerability to nicotine's reinforcing effects compared to males and progesterone may be used to counter this enhanced vulnerability. This information supports the idea that progesterone can affect behavior.[89]
- Similar to nicotine, cocaine also increases the release of dopamine in the brain. The neurotransmitter is involved in the reward center and is one of the main neurotransmitters involved with substance abuse and reliance. In a study of cocaine users, it was reported that progesterone reduced craving and the feeling of being stimulated by cocaine. Thus, progesterone was suggested as an agent that decreases cocaine craving by reducing the dopaminergic properties of the drug.[91]
Societal
In a 2012 University of Amsterdam study of 120 women, women's luteal phase (higher levels of progesterone, and increasing levels of estrogen) was correlated with a lower level of competitive behavior in gambling and math contest scenarios, while their premenstrual phase (sharply-decreasing levels of progesterone, and decreasing levels of estrogen) was correlated with a higher level of competitive behavior.[92]
Other effects
- Progesterone also has a role in skin elasticity and bone strength, in female sexuality, and the presence of progesterone receptors in certain muscle and fat tissue may hint at a role in sexually dimorphic proportions of those.[93][infringing link?]
- During pregnancy, progesterone is said to decrease uterine irritability.[94]
- During pregnancy, progesterone helps to suppress immune responses of the mother to fetal antigens, which prevents rejection of the fetus.[94]
- Progesterone raises epidermal growth factor-1 (EGF-1) levels, a factor often used to induce proliferation, and used to sustain cultures, of stem cells.[95]
- Progesterone increases core temperature (thermogenic function) during ovulation.[96][97]
- Progesterone reduces Bronchi are widened and mucus regulated. (PRs are widely present in submucosal tissue.)
- Progesterone acts as an antiinflammatory agent and regulates the immune response.
- Progesterone reduces gall-bladder activity.[98]
- Progesterone normalizes blood clotting and vascular tone, zinc and copper levels, cell oxygen levels, and use of fat stores for energy.
- Progesterone may affect gum health, increasing risk of gingivitis (gum inflammation).[99]
- Progesterone appears to prevent endometrial cancer (involving the uterine lining) by regulating the effects of estrogen.
- Progesterone plays an important role in the signaling of insulin release and pancreatic function, and may affect the susceptibility to diabetes or gestational diabetes.[100][101]
- Progesterone levels in the blood were found to be lower in women who had higher weight and higher BMI among those who became pregnant through in vitro fertilization.[102]
- Current data shows that micronized progesterone, which is chemically identical to the progesterone produced in women's bodies, in combination with estrogen in menopausal hormone therapy does not seem to have significant effects on venous thromboembolism (blood clots in veins) and ischemic stroke (lack of blood flow to the brain due to blockage of a blood vessel that supplies the brain). However, more studies need to be conducted to see whether or not micronized progesterone alone or in combined menopausal hormone therapy changes the risk of myocardial infarctions (heart attacks).[103]
- There have not been any studies done yet on the effects of micronized progesterone on hair loss due to menopause.[104]
- Despite suggestions for using hormone therapy to prevent loss of muscle mass in post-menopausal women (50 and older), menopausal hormone therapy involving either estrogen alone or estrogen and progesterone has not been found to preserve muscle mass.[105] Menopausal hormone therapy also does not result in body weight reduction, BMI reduction, or change in glucose metabolism.[106]
Biochemistry
Biosynthesis
In mammals, progesterone, like all other steroid hormones, is synthesized from pregnenolone, which itself is derived from cholesterol.
Cholesterol undergoes double oxidation to produce
The conversion of pregnenolone to progesterone takes place in two steps. First, the 3β-
Progesterone in turn is the precursor of the mineralocorticoid
Pregnenolone and progesterone can also be synthesized by yeast.[109]
Approximately 25 mg of progesterone is secreted from the ovaries per day in women, while the adrenal glands produce about 2 mg of progesterone per day.[110]
Sex | Sex hormone | Reproductive phase |
Blood production rate |
Gonadal secretion rate |
Metabolic clearance rate |
Reference range (serum levels) | |
---|---|---|---|---|---|---|---|
SI units | Non-SI units | ||||||
Men | Androstenedione | –
|
2.8 mg/day | 1.6 mg/day | 2200 L/day | 2.8–7.3 nmol/L | 80–210 ng/dL |
Testosterone | –
|
6.5 mg/day | 6.2 mg/day | 950 L/day | 6.9–34.7 nmol/L | 200–1000 ng/dL | |
Estrone | –
|
150 μg/day | 110 μg/day | 2050 L/day | 37–250 pmol/L | 10–70 pg/mL | |
Estradiol | –
|
60 μg/day | 50 μg/day | 1600 L/day | <37–210 pmol/L | 10–57 pg/mL | |
Estrone sulfate | –
|
80 μg/day | Insignificant | 167 L/day | 600–2500 pmol/L | 200–900 pg/mL | |
Women | Androstenedione | –
|
3.2 mg/day | 2.8 mg/day | 2000 L/day | 3.1–12.2 nmol/L | 89–350 ng/dL |
Testosterone | –
|
190 μg/day | 60 μg/day | 500 L/day | 0.7–2.8 nmol/L | 20–81 ng/dL | |
Estrone | Follicular phase | 110 μg/day | 80 μg/day | 2200 L/day | 110–400 pmol/L | 30–110 pg/mL | |
Luteal phase | 260 μg/day | 150 μg/day | 2200 L/day | 310–660 pmol/L | 80–180 pg/mL | ||
Postmenopause | 40 μg/day | Insignificant | 1610 L/day | 22–230 pmol/L | 6–60 pg/mL | ||
Estradiol | Follicular phase | 90 μg/day | 80 μg/day | 1200 L/day | <37–360 pmol/L | 10–98 pg/mL | |
Luteal phase | 250 μg/day | 240 μg/day | 1200 L/day | 699–1250 pmol/L | 190–341 pg/mL | ||
Postmenopause | 6 μg/day | Insignificant | 910 L/day | <37–140 pmol/L | 10–38 pg/mL | ||
Estrone sulfate | Follicular phase | 100 μg/day | Insignificant | 146 L/day | 700–3600 pmol/L | 250–1300 pg/mL | |
Luteal phase | 180 μg/day | Insignificant | 146 L/day | 1100–7300 pmol/L | 400–2600 pg/mL | ||
Progesterone | Follicular phase | 2 mg/day | 1.7 mg/day | 2100 L/day | 0.3–3 nmol/L | 0.1–0.9 ng/mL | |
Luteal phase | 25 mg/day | 24 mg/day | 2100 L/day | 19–45 nmol/L | 6–14 ng/mL | ||
Notes and sources
Notes: "The concentration of a steroid in the circulation is determined by the rate at which it is secreted from glands, the rate of metabolism of precursor or prehormones into the steroid, and the rate at which it is extracted by tissues and metabolized. The secretion rate of a steroid refers to the total secretion of the compound from a gland per unit time. Secretion rates have been assessed by sampling the venous effluent from a gland over time and subtracting out the arterial and peripheral venous hormone concentration. The metabolic clearance rate of a steroid is defined as the volume of blood that has been completely cleared of the hormone per unit time. The production rate of a steroid hormone refers to entry into the blood of the compound from all possible sources, including secretion from glands and conversion of prohormones into the steroid of interest. At steady state, the amount of hormone entering the blood from all sources will be equal to the rate at which it is being cleared (metabolic clearance rate) multiplied by blood concentration (production rate = metabolic clearance rate × concentration). If there is little contribution of prohormone metabolism to the circulating pool of steroid, then the production rate will approximate the secretion rate." Sources: See template. |
Distribution
Progesterone binds extensively to
Metabolism
The
The major
Relatively small portions of progesterone are
Metabolism of progesterone in humans[129]
|
Levels
In women, progesterone levels are relatively low during the preovulatory phase of the menstrual cycle, rise after ovulation, and are elevated during the luteal phase, as shown in the diagram above. Progesterone levels tend to be less than 2 ng/mL prior to ovulation and greater than 5 ng/mL after ovulation. If pregnancy occurs, human chorionic gonadotropin is released, maintaining the corpus luteum and allowing it to maintain levels of progesterone. Between 7 and 9 weeks, the placenta begins to produce progesterone in place of the corpus luteum in a process called the luteal-placental shift.[131]
After the luteal-placental shift, progesterone levels start to rise further and may reach 100 to 200 ng/mL at term. Whether a decrease in progesterone levels is critical for the initiation of
Progesterone levels are low in children and postmenopausal women.[132] Adult males have levels similar to those in women during the follicular phase of the menstrual cycle.
Group | P4 production | P4 levels | ||
---|---|---|---|---|
Prepubertal children |
ND | 0.06–0.5 ng/mL | ||
Pubertal girls Tanner stage I (childhood) Tanner stage II (ages 8–12) Tanner stage III (ages 10–13) Tanner stage IV (ages 11–14) Tanner stage V (ages 12–15) Follicular phase (days 1–14) Luteal phase (days 15–28) |
ND ND ND ND ND ND |
0.22 (<0.10–0.32) ng/mL 0.30 (0.10–0.51) ng/mL 0.36 (0.10–0.75) ng/mL 1.75 (<0.10–25.0) ng/mL 0.35 (0.13–0.75) ng/mL 2.0–25.0 ng/mL | ||
Oral contraceptive (anovulatory ) |
0.75–5.4 mg/day 15–50 mg/day ND |
0.02–1.2 ng/mL 4–30 ng/mL 0.1–0.3 ng/mL | ||
Postmenopausal women Oophorectomized women Oophorectomized and adrenalectomized women |
ND 1.2 mg/day <0.3 mg/day |
0.03–0.3 ng/mL 0.39 ng/mL ND | ||
Postpartum (at 24 hours) |
55 mg/day 92–100 mg/day 190–563 mg/day ND |
9–75 ng/mL 17–146 ng/mL 55–255 ng/mL 19 ng/mL | ||
Men | 0.75–3 mg/day | 0.1–0.3 ng/mL | ||
Notes: Mean levels are given as a single value and ranges are given after in parentheses. Sources: [129][133][134][135][136][137][138][139][140] |
Ranges
Blood test results should always be interpreted using the reference ranges provided by the laboratory that performed the results. Example reference ranges are listed below.
Person type | Reference range for blood test
| ||
---|---|---|---|
Lower limit | Upper limit | Unit | |
Female - menstrual cycle | (see diagram below) | ||
Female - postmenopausal | <0.2[141] |
1[141] | mL
|
<0.6[142] | 3[142] | nmol/L
| |
Female on oral contraceptives |
0.34[141] | 0.92[141] | ng/mL |
1.1[142] | 2.9[142] | nmol/L | |
Males ≥ 16 years |
0.27[141] | 0.9[141] | ng/mL |
0.86[142] | 2.9[142] | nmol/L | |
Female or male 1–9 years | 0.1[141] | 4.1[141] or 4.5[141] | ng/mL |
0.3[142] | 13[142] | nmol/L |
Sources
Animal
Progesterone is produced in high amounts in the
During human pregnancy, progesterone is produced in increasingly high amounts by the ovaries and placenta. At first, the source is the corpus luteum that has been "rescued" by the presence of human chorionic gonadotropin (hCG) from the conceptus. However, after the 8th week, production of progesterone shifts to the placenta. The placenta utilizes maternal cholesterol as the initial substrate, and most of the produced progesterone enters the maternal circulation, but some is picked up by the fetal circulation and used as substrate for fetal corticosteroids. At term the placenta produces about 250 mg progesterone per day.
An additional animal source of progesterone is milk products. After consumption of milk products the level of bioavailable progesterone goes up.[144]
Plants
In at least one plant, Juglans regia, progesterone has been detected.[145] In addition, progesterone-like steroids are found in Dioscorea mexicana. Dioscorea mexicana is a plant that is part of the yam family native to Mexico.[146] It contains a steroid called diosgenin that is taken from the plant and is converted into progesterone.[147] Diosgenin and progesterone are also found in other Dioscorea species, as well as in other plants that are not closely related, such as fenugreek.
Another plant that contains substances readily convertible to progesterone is
Many other Dioscorea species of the yam family contain steroidal substances from which progesterone can be produced. Among the more notable of these are
Medical use
Progesterone is used as a
It is also used in women to support
Chemistry
Progesterone is a
Synthesis
Progesterone is commercially produced by semisynthesis. Two main routes are used: one from yam diosgenin first pioneered by Marker in 1940, and one based on soy phytosterols scaled up in the 1970s. Additional (not necessarily economical) semisyntheses of progesterone have also been reported starting from a variety of steroids. For the example, cortisone can be simultaneously deoxygenated at the C-17 and C-21 position by treatment with iodotrimethylsilane in chloroform to produce 11-keto-progesterone (ketogestin), which in turn can be reduced at position-11 to yield progesterone.[161]
Marker semisynthesis
An economical semisynthesis of progesterone from the plant steroid diosgenin isolated from yams was developed by Russell Marker in 1940 for the Parke-Davis pharmaceutical company.[162] This synthesis is known as the Marker degradation.
The
Soy semisynthesis
Progesterone can also be made from the
Total synthesis
A
History
Veterinary use
The use of progesterone tests in dog breeding to pinpoint ovulation is becoming more widely used. There are several tests available but the most reliable test is a blood test with blood drawn by a veterinarian and sent to a lab for processing. Results can usually be obtained with 24 to 72 hours. The rationale for using progesterone tests is that increased numbers begin in close proximity to preovulatory surge in gonadotrophins and continue through ovulation and estrus. When progesterone levels reach certain levels they can signal the stage of estrus the female is. Prediction of birth date of the pending litter can be very accurate if ovulation date is known. Puppies deliver with a day or two of 9 weeks gestation in most cases. It is not possible to determine pregnancy using progesterone tests once a breeding has taken place, however. This is due to the fact that, in dogs, progesterone levels remain elevated throughout the estrus period.[177]
Pricing
Pricing for progesterone can vary depending location, insurance coverage, discount coupons, quantity, shortages, manufacturers, brand or generic versions, different pharmacies, and so on. As of currently, 30 capsules of 100 mg of the generic version, Prometrium, from CVS Pharmacy is around $40 without any discounts or insurance applied. The brand version, Progesterone, is around $450 for 30 capsules without any discounts or insurance applied.[178] In comparison, Walgreens offers 30 capsules of 100 mg in the generic version for $51 without insurance or coupons applied. The brand name costs around $431 for 30 capsules of 100 mg.[179]
References
- This article incorporates text available under the CC BY-SA 3.0 license.
- ^ ISBN 978-0-323-32195-2. Archivedfrom the original on 14 January 2023. Retrieved 29 October 2017.
- ISBN 978-1-4684-4834-4. Archivedfrom the original on 14 January 2023. Retrieved 4 July 2015.
- ^ "progesterone (CHEBI:17026)". ChEBI. European Molecular Biology Laboratory-EBI. Archived from the original on 20 March 2016. Retrieved 4 July 2015.
- ^ "Progesterone_msds". Archived from the original on 12 February 2021. Retrieved 19 April 2018.
- ^ S2CID 27018468.
- ^ PMID 8513955.
- ISBN 978-1-4511-4847-3.
- ISBN 978-0-7234-3455-9. Archivedfrom the original on 14 January 2023. Retrieved 5 October 2016.
- PMID 9328296.
- ISBN 978-1-118-34489-7. Archivedfrom the original on 14 January 2023. Retrieved 27 June 2015.
- ]
- ^ S2CID 31974637.
- ^ ISBN 978-1-4496-5800-7.
- ^ S2CID 14952168.
- S2CID 58620122.
Evidence has accrued that normal progesterone (and ovulation), as well as physiological estradiol levels, is necessary during ciswomen's premenopausal menstrual cycles for current fertility and long-term health; transgender women may require progesterone therapy and similar potential physiological benefits
- ISBN 9783527607495.
- ^ ISBN 978-1-4613-2157-6. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- PMID 22687885.
- S2CID 3826650.
- S2CID 40096058.
- PMID 30087538.
- PMID 28396637.
- S2CID 44931783.
- PMID 21084640.
- ^ PMID 8282004.
- S2CID 41756726.
- PMID 18060946.
- PMID 23209664.
- S2CID 221753076.
- PMID 12372848.
- PMID 9727070.
- ISBN 978-3-642-55041-6. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- ^ ISBN 978-0-12-440906-4. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- ISBN 978-1-60913-345-0.
- ISBN 978-1-4816-7550-5. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- S2CID 4431334.
- S2CID 4340309.
- .
- PMID 2328727.
- ^ from the original on 27 November 2023. Retrieved 2 August 2023.
- ^ ISBN 978-0-12-387584-6. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- ^ ISBN 978-0-7020-3489-3.
- PMID 13263410.
- ^ S2CID 257943362.
- ^ PMID 30763313.
- PMID 24793988.
- PMID 8636249.
- S2CID 260318879.
- PMID 10837122.
- PMID 14606954.
- PMID 15322137.
- ISBN 9780321887603.
- S2CID 28390608.
- ^ a b Bowen R (6 August 2000). "Placental Hormones". Archived from the original on 17 May 2007. Retrieved 12 March 2008.
- PMID 25406186.
- ^ S2CID 32239449.
- PMID 35168930.
- PMID 22844349.
- ^ PMID 26266959.
- ISBN 978-1-4557-2758-2. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- PMID 24718936.
- ^ PMID 23705924.
- ^ S2CID 20808536.
- ^ PMID 31512725.
- PMID 31474332.
- (PDF) from the original on 2 February 2024. Retrieved 2 February 2024.
- PMID 27456847.
- S2CID 46922084.
- S2CID 3850275.
- ^ S2CID 20392538.
- ^ S2CID 6077829.
- ISBN 978-1-4614-5559-2.
- from the original on 23 September 2020. Retrieved 2 August 2023.
- ^ "Homosexuality may help us bond". UoP News. Archived from the original on 2 July 2019. Retrieved 2 July 2019.
- ^ "Having homosexual thoughts 'is an essential part of human evolution' study suggests". The Telegraph. 25 November 2014. Archived from the original on 15 February 2018. Retrieved 4 April 2018.
- ^ "New Study Identifies Evolutionary Basis Of Homosexuality". HuffPost. 26 November 2014. Archived from the original on 27 November 2023. Retrieved 21 October 2023.
- ^ from the original on 5 March 2021. Retrieved 28 June 2019.
- PMID 15135772.
- PMID 24065876.
- PMID 10833057.
- PMID 18188998.
- PMID 27143417.
- ^ PMID 22101209.
- ^ PMID 17826842.
- PMID 22088981.
- PMID 26746666.
- PMID 19401954.
- PMID 21534727.
- ^ PMID 21186920.
- PMID 22474108.
- PMID 21796112.
- (PDF) from the original on 2 February 2024. Retrieved 2 February 2024.
- ISBN 978-81-317-0031-0.
- ^ ISBN 978-0-323-29296-2.
- PMID 17074804.
- ^ Nosek TM. "Section 5/5ch9/s5ch9_13". Essentials of Human Physiology. Archived from the original on 24 March 2016.
- ISBN 978-1-4684-1782-1, archivedfrom the original on 29 August 2021, retrieved 22 March 2021
- PMID 3184927.
- ^ "Hormones and Oral Health". WebMD. Archived from the original on 18 June 2016. Retrieved 22 July 2013.
- PMID 12438645.
- S2CID 38209977.
- PMID 34278354.
- S2CID 246487187.
- S2CID 231757325.
- PMID 31461147.
- S2CID 53782622.
- ISSN 2002-4436.
- ISBN 0-471-49641-3.
- S2CID 852617.
- ISBN 978-1-60913-345-0. Archivedfrom the original on 14 January 2023. Retrieved 19 July 2018.
- ^ Progesterone - Drugs.com, archived from the original on 27 March 2019, retrieved 23 August 2015
- ^ ISBN 978-0-323-03309-1. Archivedfrom the original on 10 January 2023. Retrieved 6 November 2016.
- ^ ISBN 978-0-08-057109-6.
- ^ S2CID 44601264.
- ISBN 978-0-323-44595-5.
- ^ S2CID 24616324.
- ^ ISBN 978-0-12-397769-4.
- ^ ISBN 978-1-60327-864-5. Archivedfrom the original on 14 January 2023. Retrieved 6 November 2016.
- PMID 21094889.
- ^ ISBN 978-0-412-02791-8.
- PMID 21182831.
- PMID 15492972.
- ISBN 978-1-4987-0230-0.
- ISBN 978-0-323-14971-6. Archivedfrom the original on 14 January 2023. Retrieved 6 November 2016.
- PMID 23322723.
- S2CID 3700135.
- ^ ]
- S2CID 9831739.
- ^ PMID 945344.
- S2CID 524952.
- PMID 4688578.
- ^ NIH Clinical Center (16 August 2004). "Progesterone Historical Reference Ranges". United States National Institutes of Health. Archived from the original on 9 January 2009. Retrieved 12 March 2008.
- ISBN 978-1-4557-4502-9. Archivedfrom the original on 27 February 2024. Retrieved 23 August 2023.
- ISBN 978-0-7817-1750-2. Archivedfrom the original on 27 February 2024. Retrieved 23 August 2023.
- ISBN 978-1-4613-2157-6. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- ISBN 978-94-011-6255-5. Archivedfrom the original on 14 January 2023. Retrieved 1 February 2016.
- ISBN 978-1-4160-4907-4. Archivedfrom the original on 10 January 2023. Retrieved 23 August 2023.
- ISBN 978-0-323-05405-8. Archivedfrom the original on 11 January 2023. Retrieved 23 August 2023.
- from the original on 1 October 2023. Retrieved 23 August 2023.
- ^ Little, A. B., & Billiar, R. B. (1983). Progestagens. In Endocrinology of Pregnancy, 3rd Edition (pp. 92–111). Harper and Row Philadelphia. https://scholar.google.com/scholar?cluster=2512291948467467634 Archived 22 February 2022 at the Wayback Machine
- ^ a b c d e f g h i Progesterone Reference Ranges, Performed at the Clinical Center at the National Institutes of Health, Bethesda MD, 03Feb09
- ^ a b c d e f g h Converted from mass values using molar mass of 314.46 g/mol
- S2CID 88035135.
- ^ Goodson III WH, Handagama P, Moore II DH, Dairkee S (13 December 2007). "Milk products are a source of dietary progesterone". 30th Annual San Antonio Breast Cancer Symposium. pp. abstract # 2028. Archived from the original on 20 September 2008. Retrieved 12 March 2008.
- S2CID 26467578.
- PMID 12255132.
- PMID 16946542.
- (PDF) from the original on 3 August 2022. Retrieved 2 April 2022.
- S2CID 962216.
- S2CID 95193700.
- ISBN 81-308-0003-9.
- PMID 28159148.
- S2CID 225100434.
- PMID 25113944.
- PMID 26443945.
- S2CID 40753277.
- PMID 28989916.
- PMID 32609084.
- ^ ISBN 978-1-4757-2085-3.
- ^ ISBN 978-3-88763-075-1.
- PMID 3815593.
- ^ .
- .
- .
- .
- PMID 915584.
- ^ "Nova Transcripts: Forgotten Genius". PBS.org. 6 February 2007. Archived from the original on 11 October 2018. Retrieved 8 September 2017.
- ^ "Giants of the Past". lipidlibrary.aocs.org. Archived from the original on 15 April 2012.
- ^ PMID 5131151.
- from the original on 12 August 2021. Retrieved 12 August 2021.
- ^ ISBN 978-0-19-513021-8. Archivedfrom the original on 14 January 2023. Retrieved 5 October 2016.
- ISBN 978-1-134-71411-7.
- .
- ISBN 978-1-4684-5275-4. Archivedfrom the original on 14 January 2023. Retrieved 5 October 2016.
- ^ Rolleston HD (1936). The Endocrine Organs in Health and Disease: With an Historical Review. Oxford University Press, H. Milford. p. 406. Archived from the original on 14 January 2023. Retrieved 5 October 2016.
- S2CID 35867375.
- ^ Refsal K (February 2009). "Interpretation of Serum Progesterone Results for Management of Breeding in Dogs" (PDF). Webcd.endo.ref. Archived from the original on 29 August 2021. Retrieved 26 February 2018.
- ^ "Progesterone Prices, Coupons & Savings Tips - GoodRx". www.goodrx.com. Archived from the original on 30 March 2023. Retrieved 1 August 2023.
- ^ "Progesterone Prices, Coupons & Savings Tips - GoodRx". www.goodrx.com. Archived from the original on 30 March 2023. Retrieved 1 August 2023.
External links
- Progesterone MS Spectrum
- Progesterone at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Kimball JW (27 May 2007). "Progesterone". Kimball's Biology Pages. Archived from the original on 18 June 2008. Retrieved 18 June 2008.